• The Korean Journal of Physiology and Pharmacology
• /
• 제24권6호
• /
• pp.481-492
• /
• 2020

The present study aimed to examine the effect of allyl isothiocyanate (AITC) on chronic obstructive pulmonary disease and to investigate whether upregulation of multidrug resistance-associated protein 1 (MRP1) associated with the activation of the PARK7 (DJ-1)/nuclear factor erythroid 2-related factor 2 (Nrf2) axis. Lung function indexes and histopathological changes in mice were assessed by lung function detection and H&E staining. The expression levels of Nrf2, MRP1, heme oxygenase-1 (HO-1), and DJ-1 were determined by immunohistochemistry, Western blotting and reverse transcription-quantitative polymerase chain reaction. Next, the expression of DJ-1 in human bronchial epithelial (16HBE) cells was silenced by siRNA, and the effect of DJ-1 expression level on cigarette smoke extract (CSE)-stimulated protein degradation and AITC-induced protein expression was examined. The expression of DJ-1, Nrf2, HO-1, and MRP1 was significantly decreased in the wild type model group, while the expression of each protein was significantly increased after administration of AITC. Silencing the expression of DJ-1 in 16HBE cells accelerated CSE-induced protein degradation, and significantly attenuated the AITC-induced mRNA and protein expression of Nrf2 and MRP1. The present study describes a novel mechanism by which AITC induces MRP1 expression by protecting against CS/CSE-mediated DJ-1 protein degradation via activation of the DJ-1/Nrf2 axis.

• 대한핵의학회지
• /
• 제16권1호
• /
• pp.1-6
• /
• 1982

To evaluate the usefulness of radionuclide cardiac angiography in the assessment of right ventricular function, we measured right ventricular ejection fraction (RVEF) using single pass method. In 12 normal persons, RVEF averaged $52.7{\pm}5.9%(mean{\pm}S.D.)$. In 25 patients with chronic obstructive lung disease, RVEF was $37.2{\pm}10.6%$ and significantly lower than that of normal persons (p<0.01). All 10 patients with right ventricular failure had abnormal RVEF, which was significantly lower than that of 14 patients without right ventricular failure ($27.6{\pm}5.7%,\;43.9{\pm}8.5%$, respectively. p<0.01). It concluded thal RVEF measured by single pass radionuclide cardiac angiography was a useful, noninvasive method to assess right ventricular function.

• Molecules and Cells
• /
• 제42권4호
• /
• pp.333-344
• /
• 2019

Various genetic and environmental factors are known to be associated with chronic obstructive pulmonary disease (COPD). We identified COPD-related differentially expressed genes (DEGs) using 189 samples accompanying either adenocarcinoma (AC) or squamous cell carcinoma (SC), comprising 91 normal and 98 COPD samples. DEGs were obtained from the intersection of two DEG sets separately identified for AC and SC to exclude the influence of different cancer backgrounds co-occurring with COPD. We also measured patient samples named group 'I', which were unable to be determined as normal or COPD based on alterations in gene expression. The Gene Ontology (GO) analysis revealed significant alterations in the expression of genes categorized with the 'cell adhesion', 'inflammatory response', and 'mitochondrial functions', i.e., well-known functions related to COPD, in samples from patients with COPD. Multi-omics data were subsequently integrated to decipher the upstream regulatory changes linked to the gene expression alterations in COPD. COPD-associated expression quantitative trait loci (eQTLs) were located at the upstream regulatory regions of 96 DEGs. Additionally, 45 previously identified COPD-related miRNAs were predicted to target 66 of the DEGs. The eQTLs and miRNAs might affect the expression of 'respiratory electron transport chain' genes and 'cell proliferation' genes, respectively, while both eQTLs and miRNAs might affect the expression of 'apoptosis' genes. We think that our present study will contribute to our understanding of the molecular etiology of COPD accompanying lung cancer.

• Biomolecules & Therapeutics
• /
• 제28권3호
• /
• pp.250-258
• /
• 2020

Emphysema, a major component of chronic obstructive pulmonary disease (COPD), is a leading cause of human death worldwide. The progressive deterioration of lung function that occurs in the disease is caused by chronic inflammation of the airway and destruction of the lung parenchyma. Despite the main impact of inflammation on the pathogenesis of emphysema, current therapeutic regimens mainly offer symptomatic relief and preservation of lung function with little therapeutic impact. In the present study, we aimed to discover novel therapeutics that suppress the pathogenesis of emphysema. Here, we show that LJ-2698, a novel and highly selective antagonist of the adenosine A₃ receptor, a G protein-coupled receptor involved in various inflammatory diseases, significantly reversed the elastase-induced destructive changes in murine lungs. We found that LJ-2698 significantly prevented elastase-induced airspace enlargement, resulting in restoration of pulmonary function without causing any obvious changes in body weight in mice. LJ-2698 was found to inhibit matrix metalloproteinase activity and pulmonary cell apoptosis in the murine lung. LJ-2698 treatment induced increases in anti-inflammatory cytokines in macrophages at doses that displayed no significant cytotoxicity in normal cell lines derived from various organs. Treatment with LJ-2698 significantly increased the number of anti-inflammatory M2 macrophages in the lungs. These results implicate the adenosine A₃ receptor in the pathogenesis of emphysema. Our findings also demonstrate the potential of LJ-2698 as a novel therapeutic/preventive agent in suppressing disease development with limited toxicity.

• Tuberculosis and Respiratory Diseases
• /
• 제39권1호
• /
• pp.55-61
• /
• 1992

연구배경 : 폐장은 악성종양이 가장 잘 전이하는 장기로 대부분은 혈행성으로 하나 또는 다수의 결절형태로 나타나나, 드물게는 림프관을 따라 전파되어 흉부 X선 검사상 미만성 간질성 폐침윤 양상으로 나타나기도한다. 때로는 이러한 림프관성 전이가 원발성암의 증상이 뚜렷치 않으면서 호흡기 증상과 흉부 X선 검사상 미만성 간질성 폐침윤이 보여 다른 간질성 폐질환과의 감별을 요하는데 이러한 경우를 경기관지 폐생검으로 암종성 림프관염이 진단되었던 5예를 경험하였기에 보고하는 바이다. 방법 : 임상소견, 폐기능검사, 흉부 전산화 단층촬영, 기관지 폐포 세척술과 경기관지 폐생검 검사로 진단을 얻었다. 결과 : 종양의 원발병소는 5명중 3명이 위암이었고, 2명은 폐암으로 생각되었다. 폐기능검사상 2명의 환자에서는 폐확산능이 감소된 제한성 환기장애를 보인 반면 한명에서는 폐쇄성 환기장애를 보였다. 기관지 폐포 세척술에서는 4명의 환자에서 모두 림프구 증가소견을 보였고 세포학적 검사상 이중 한명에서는 암세포도 관찰되었다. 경기관지 폐생검 검사에서 림프관에만 국한된 암세포가 관찰되었고, 이들의 cell type은 4명이 선암종이었고, 1명은 편평 상피 암종이었다. 결론 : 드물게, 암종성 림프관염은 원발성암의 증상이 없이 미만성 간질성 폐질환으로 발현될 수 있으며, 경기관지 폐생검 검사로 쉽게 진단되어 질수 있다.

• Journal of Chest Surgery
• /
• 제26권7호
• /
• pp.532-537
• /
• 1993

To assess the therapy of spontaneous pneumothorax in the aged patients, the treatment methods and results in 60 patients 50 years of age or older were retrospectively reviewed. Most of the patients were male [56 of 60 patients] and the major underlying lung diseases associated with spontaneous pneumothorax were tuberculosis [32 patients] and chronic obstructive lung disease [20 patients]. The recurrence rate of thoracostomy tube drainage with or without chemical pleurodesis using tetracycline was 39.6% [21 of 53 patients], but there was no recurrence in the patients treated with open thoracotomy, pleural abrasion, and chemical pleurodesis using talcum powder[Asbestosis free]. In the patients treated with open thoracotomy, the bullous or bleb lesions were placed in the various sites of both lungs. We concluded that even though thoracostomy tube drainage is the first choice of therapy for spontaneous pneumothorax in the aged patients, the recurrence rate is high, especially in the patients with persistent air leakage for more than 2 days, and the open thoracotomy with pleural abrasion and chemical pleurodesis using talcum powder can prevent the recurrence in the selected patients.

• Tuberculosis and Respiratory Diseases
• /
• 제79권1호
• /
• pp.22-30
• /
• 2016

Background: The purpose of this study was to document outcomes following withdrawal of a single inhaler (step-down) in chronic obstructive pulmonary disease (COPD) patients on triple therapy (long-acting muscarinic antagonist and a combination of long-acting ${\beta}2$-agonists and inhaled corticosteroid), which a common treatment strategy in clinical practice. Methods: Through a retrospective observational study, COPD patients receiving triple therapy over 2 years (triple group; n=109) were compared with those who had undergone triple therapy for at least 1 year and subsequently, over 9 months, initiated inhaler withdrawal (step-down group, n=39). The index time was defined as the time of withdrawal in the step-down group and as 1 year after the start of triple therapy in the triple group. Results: Lung function at the index time was superior and the previous exacerbation frequency was lower in the step-down group than in the triple group. Step-down resulted in aggravating disease symptoms, a reduced overall quality of life, decreasing exercise performance, and accelerated forced expiratory volume in 1 second ($FEV_1$) decline ($54.7{\pm}15.7mL/yr$ vs. $10.7{\pm}7.1mL/yr$, p=0.007), but there was no observed increase in the frequency of exacerbations. Conclusion: Withdrawal of a single inhaler during triple therapy in COPD patients should be conducted with caution as it may impair the exercise capacity and quality of life while accelerating $FEV_1$ decline.

• 대한한의학회지
• /
• 제39권4호
• /
• pp.171-176
• /
• 2018

Background: Small cell lung cancer (SCLC) tends to grow more rapidly and spread much faster than non-small cell lung cancer (NSCLC). A concurrent combination of chemotherapy and thoracic radiotherapy is suggested as the standard conventional treatment, but it is more challenging for elderly patients having pulmonary and cardiovascular comorbidities. Case presentation: Here we present a case of an 80-year-old male, current smoker diagnosed with SCLC in limited stage T3N0M0 (36mm right upper lobe, satellite nodule) in Dec, 2015. The standard concurrent chemoradiotherapy was not available for his comorbidities, which included chronic obstructive pulmonary disease (COPD) and angina pectoris. Furthermore, he and his family refused the recommended chemotherapy or radiotherapy exclusively. Alternatively, he received various non-conventional treatments including local radiofrequency hyperthermia, mistletoe, and Traditional Korean medicine including acupuncture, moxibustion and herbs since Jan. 2016. Despite the progression in primary tumor size, there have been no other distant relapse so far, and the patient has been in stable condition ever since. Conclusion: We suggest that a combination of various alternative treatments could be a candidate for elderly patients intolerable to conventional cytotoxic treatments.

• Tuberculosis and Respiratory Diseases
• /
• 제66권3호
• /
• pp.186-191
• /
• 2009

연구배경: 골다공증은 만성폐쇄성폐질환 환자의 중요한 동반질환 중 하나이다. 저자들은 COPD 환자에서 골다공증의 유병률과 위험인자를 알아 보고자 하였다. 방 법: 안정 상태인 COPD 환자 51명과 이들과 나이와 성별을 일치시킨 대조군 41명에서 요추골과 대퇴골의 골밀도를 측정하였다. 임상기록과 검사결과를 검토하여, COPD 환자에서 골다공의 위험인자를 분석하였다. 결 과: COPD 환자에서, T점수가 -2.5 이하인, 골다공증의 유병률은 47%였고, 대조군에서 32%였다. 특히 대퇴골목의 T점수를 기준으로 한 골다공증의 유병률은 COPD 환자에서 대조군에 비해 유의하게 높았다(26% vs. 5%; p=0.006). COPD 환자의 요추와(p=0.025) 대퇴골목의 평균 T 점수는 대조군보다 유의하게 낮았다(p=0.001). COPD 환자에서 $FEV_1$의 정상예측치에 대한 비율과(p=0.019; odds ratio [OR], 0.955; 95% confidence interval [CI], 0.919-0.993) 연령이 골다공증 발생과 관련된 독립적인 위험인자였다(p=0.024; OR, 1.144; 95% CI, 1.018-1.287). 결 론: COPD 환자에서 골다공증의 유병률은 연령과 성별을 일치시킨 대조군보다 높다. 특히 대퇴골의 T점수가 요추보다 COPD 환자와 대조군의 골밀도의 차이를 더 분명하게 보여 주었다. COPD 환자에서 $FEV_1$이 낮을수록, 나이가 많을수록 골다공증 발생 위험이 크게 증가한다.

• 대한한의학회지
• /
• 제39권3호
• /
• pp.41-50
• /
• 2018

Objectives: The study is aimed to utilize Taesikbub and Lung-doyinbub described in "Dong-Ui-Bo-Gam" as a Korean Traditional Pulmonary Rehabilitation Exercise. Methods: We preliminary researched pulmonary rehabilitation exercise using domestic and international databases and old literatures of Korean Medicine. Then made a draft of Korean Traditional Pulmonary Rehabilitation Exercise based on "Dong-Ui-Bo-Gam". After organizing expert group for verifying the draft of the exercise, we developed the final Korean Traditional Pulmonary Rehabilitation Exercise. Results: The Korean Traditional Pulmonary Rehabilitation Exercise is composed of 5 actions including breathing method, flexibility exercise, percussion and hitting teeth. This exercise is recommended twice a day for at least 5 days per week under the supervision of specialist. It is expected to improve physical activity, dyspnea, health-related quality of life (HRQoL) as well as psychiatric symptoms by breathing deep and slow and exercising the thorax and upper limb muscles. Conclusion: Taesikbub, Lung-doyinbub in "Dong-Ui-Bo-Gam" may be suggested as a better pulmonary rehabilitation exercise for patients of chronic lung disease.